Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ALT
$4.00
-1.48%
Analyze
0
3M
-2.0%
1Y
-40.2%
Market Cap:
$353.03M
Altimmune Inc
Healthcare |
Biotechnology
Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.
Click "Analyze" to generate stock analysis
ALT Price Trend and Signals
ALT Option Volumes & Open Interests (aggregated)
ALT Put Call Ratios and IV (aggregated)
ALT Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-27
Somewhat Bullish
macd_signal
Golden cross above zero detected.
2025-10-27
Somewhat Bullish
price_signal
Quarterly high detected.
2025-10-22
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-21
Somewhat Bullish
macd_signal
Golden cross above zero detected.
2025-10-21
Somewhat Bullish
price_signal
Monthly high detected.
2025-10-16
Somewhat Bearish
macd_signal
Dead cross above zero detected.